Compliance Rate

Compliance Rate 0.0%
Compliant submissions 0
Incompliant submissions 1
Total trials 1

My Organizations' Clinical Trials

Showing 1150 of 1322 entries
View as:

Cabozantinib in Combination with Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04878029 Org: User:
Start: 07/23/21 End: 12/21/26 Due: 12/21/27

Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease

Phase: N/A Priority: Normal
NCT ID: NCT03304821 Org: User:
Start: 12/19/17 End: 12/31/25 Due: 12/31/26

Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04848519 Org: User:
Start: 05/20/21 End: 01/01/27 Due: 01/01/28

Inflammation-Induced CNS Glutamate Changes in Depression

Phase: N/A Priority: Normal
NCT ID: NCT03004443 Org: User:
Start: 05/15/17 End: 11/27/19 Due: 11/27/20

Electronic Pre-exposure Prophylaxis (PrEP) Initiation and Maintenance Home Care System

Phase: N/A Priority: Normal
NCT ID: NCT03729570 Org: User:
Start: 05/28/19 End: 05/31/22 Due: 05/31/23

A Mobile Personal Health Record for Behavioral Health Homes

Phase: N/A Priority: Normal
NCT ID: NCT01890226 Org: User:
Start: 11/30/14 End: 01/31/19 Due: 01/31/20

Follow Up on Freestyle Valves in Children

Phase: N/A Priority: Normal
NCT ID: NCT00385112 Org: User:
Start: 11/30/06 End: 12/31/16 Due: 12/31/17

Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05208307 Org: User:
Start: 07/21/22 End: 10/21/26 Due: 10/21/27

Web-based Physical Activity Intervention to Promote Physical Activity

Phase: N/A Priority: Normal
NCT ID: NCT05803304 Org: User:
Start: 10/16/23 End: 03/13/25 Due: 03/13/26

Brief Interventions to Create Smoke-Free Home Policies in Low-Income Households

Phase: N/A Priority: Normal
NCT ID: NCT01625468 Org: User:
Start: 06/30/12 End: 07/31/13 Due: 07/31/14

Suramin in Treating Patients With Recurrent Primary Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00002639 Org: User:
Start: 07/31/95 End: 05/31/04 Due: 05/31/05

Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil

Phase: N/A Priority: Normal
NCT ID: NCT00400205 Org: User:
Start: 08/31/06 End: 09/30/09 Due: 09/30/10

Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits

Phase: N/A Priority: Normal
NCT ID: NCT04352101 Org: User:
Start: 09/23/20 End: 07/25/22 Due: 07/25/23

MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04762199 Org: User:
Start: 02/24/21 End: 12/27/26 Due: 12/27/27

Aflac ST1001 Prolonged Isotretinoin

Phase: N/A Priority: Normal
NCT ID: NCT01319838 Org: User:
Start: 03/31/11 End: 12/31/13 Due: 12/31/14

Hepatitis C in Adults Who Underwent Congenital Heart Surgery Before Screening

Phase: N/A Priority: Normal
NCT ID: NCT00359099 Org: User:
Start: 01/31/80 End: 07/31/06 Due: 07/31/07

Evaluation of the Quality of Self-collected Blood Spot Specimens for Laboratory HIV Testing - An InvolveMENt Sub Study

Phase: N/A Priority: Normal
NCT ID: NCT02043041 Org: User:
Start: 01/31/14 End: 05/31/15 Due: 05/31/16

Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With High-Risk Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03756896 Org: User:
Start: 01/25/19 End: 06/30/26 Due: 06/30/27

Comparison of Sepsis Prediction Algorithms

Phase: N/A Priority: Normal
NCT ID: NCT05943938 Org: User:
Start: 06/30/25 End: 12/31/25 Due: 12/31/26

Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04524702 Org: User:
Start: 09/14/20 End: 08/14/24 Due: 08/14/25

An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique

Phase: N/A Priority: Normal
NCT ID: NCT06865768 Org: User:
Start: 04/18/25 End: 12/31/29 Due: 12/31/30

Chaplain-Delivered Compassion Meditation to Improve Quality of Life in Patients Receiving a Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT05274763 Org: User:
Start: 03/21/22 End: 05/25/22 Due: 05/25/23

Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)

Phase: N/A Priority: Normal
NCT ID: NCT04404530 Org: User:
Start: 10/08/19 End: 11/30/27 Due: 11/30/28

Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT04018937 Org: User:
Start: 03/22/19 End: 11/30/26 Due: 11/30/27

Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department

Phase: N/A Priority: Normal
NCT ID: NCT00590317 Org: User:
Start: 03/31/05 End: 09/30/08 Due: 09/30/09